Maqbool M, Gani I. Utilization of Statins in Reducing Comorbidities of Diabetes Mellitus: A Systematic Review. Journal of Pharmacy Practice and Community Medicine. 2018;4(4):193–6.

Article  Google Scholar 

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.

Article  PubMed  Google Scholar 

Shora HA. Pattern of Statin use in patients with diabetes mellitus type 2 for primary and secondary prevention of cardiovascular disease in Saudi Arabia. African J Diabetes Med. 2020;28(2):1–8.

Google Scholar 

Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, et al. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13(3):2300–12.

Article  PubMed  Google Scholar 

Ampofo AG, Boateng EB. Beyond 2020: Modelling obesity and diabetes prevalence. Diab Res Clin Pract. 2020;167:108362.

Article  Google Scholar 

Alwhaibi M, Altoaimi M, AlRuthia Y, Meraya AM, Balkhi B, Aldemerdash A, et al. Adherence to statin therapy and attainment of LDL cholesterol goal among patients with type 2 diabetes and dyslipidemia. Patient preference and adherence. 2019;13:2111–8.

Article  PubMed  PubMed Central  Google Scholar 

Naeem F, McKay G, Fisher M. Cardiovascular outcomes trials with statins in diabetes. British journal of diabetes. 2018;18(1):7–13.

Article  Google Scholar 

Vesa CM, Popa L, Popa AR, Rus M, Zaha AA, Bungau S, et al. Current data regarding the relationship between type 2 diabetes mellitus and cardiovascular risk factors. Diagnostics. 2020;10(5):314.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borges RdP, Degobi NAH, Bertoluci MC. Choosing statins: a review to guide clinical practice. Arch Endocrinol Metabol. 2020;64:639–53.

Google Scholar 

Demoz GT, Wahdey S, Kasahun GG, Hagazy K, Kinfe DG, Tasew H, et al. Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia. BMC Res Notes. 2019;12(1):1–7.

Article  CAS  Google Scholar 

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet. 2004;364(9435):685–96.

Article  CAS  Google Scholar 

Naumovska Z, Nestorovska AK, Grozdanova A, Hristova K, Dimovski A, Suturkova L, et al. Evaluation of statin utilization in the Republic of Macedonia during 2013–2016. ClinicoEconomics and Outcomes Research. 2018;10:339–47.

Article  PubMed  PubMed Central  Google Scholar 

American Diabetes Association. Cardiovascular disease and risk management. Sec. 8. In Standards of Medical Care in Diabetesd2015. Diabetes Care. 2015;38(Suppl. 1):S49–57. https://doi.org/10.2337/dc15-S011.

American Diabetes Association. Cardiovascular disease and risk management. Sec. 8. In Standards of Medical Care in Diabetesd2016. Diabetes Care. 2016;39(Suppl. 1):S60–71. https://doi.org/10.2337/dc16-S011.

Elnaem MH, Mohamed MHN, Huri HZ, Shah ASM. Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings. Therapeutics and Clinical Risk Management. 2019;15:137–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leino AD, Dorsch MP, Lester CA. Changes in statin use among US adults with diabetes: a population-based analysis of NHANES 2011–2018. Diabetes Care. 2020;43(12):3110–2.

Article  PubMed  Google Scholar 

Fu AZ, Zhang Q, Davies MJ, Pentakota S-R, Radican L, Seck T. Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study. Curr Med Res Opin. 2011;27(5):1035–40.

Article  CAS  PubMed  Google Scholar 

Hammad MA, Sulaiman SAS, Aziz NA, Noor DAM. Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice. Journal of research in medical sciences. 2019;24:15–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–104.

Article  PubMed  Google Scholar 

Wu J, Zhu S, Yao GL, Mohammed MA, Marshall T. Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study. PLoS ONE. 2013;8(7):e67611.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones N, Fischbacher C, Guthrie B, Leese G, Lindsay R, McKnight J, et al. Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006–2008. Diabet Med. 2014;31(6):640–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chamberlain AM, Cohen SS, Killian JM, Monda KL, Weston SA, Okerson T. Lipid-lowering prescription patterns in patients with diabetes mellitus or cardiovascular disease. Am J Cardiol. 2019;124(7):995–1001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zartab S, Abbassian H, Koopaei NN, Hajimolaali M. Despite affordability, low utilization of lipid lowering drugs in Iran: Trend analysis and benchmarking 2005–2016. Iran J Pharmaceut Res: IJPR. 2019;18(2):1117.

CAS  Google Scholar 

Gupta R, Lodha S, Sharma KK, Sharma SK, Gupta S, Asirvatham AJ, et al. Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2. BMJ Open Diab Res Care. 2016;4(1):e000275.

Article  PubMed  PubMed Central  Google Scholar 

Elnaem MH, Mohamed MHN, Huri HZ, Azarisman SM, Elkalmi RM. Statin therapy prescribing for patients with type 2 diabetes mellitus: a review of current evidence and challenges. J Pharmacy Bioallied Sci. 2017;9(2):80.

Article  CAS  Google Scholar 

Taghizadeh-Ghehi M, Mousavi S, Laki B, Kargar M, Javadi MR, Gholami KH. Physicians’ compliance with order entry forms for intravenous pantoprazole in a tertiary care hospital. Acta Medica Iranica. 2023;61(6):163–73.

Lin I, Sung J, Sanchez RJ, Mallya UG, Friedman M, Panaccio M, et al. Patterns of statin use in a real-world population of patients at high cardiovascular risk. J Manag Care Spec Pharm. 2016;22(6):685–98.

PubMed  Google Scholar 

Halava H, Huupponen R, Pentti J, Kivimäki M, Vahtera J. Predictors of first-year statin medication discontinuation: a cohort study. J Clin Lipidol. 2016;10(4):987–95.

Article  PubMed  PubMed Central  Google Scholar 

Riaz H, Khan AR, Khan MS, Rehman KA, Alansari SAR, Gheyath B, et al. Meta-analysis of placebo-controlled randomized controlled trials on the prevalence of statin intolerance. Am J Cardiol. 2017;120(5):774–81.

Article  CAS  PubMed  Google Scholar 

Shaik Alavudeen S, Mohammed Alakhali K. Mohammad Asif Ansari S, Abdulla Khan N. Prescribing pattern of antihypertensive drugs in diabetic patients of Southern Province, Kingdom of Saudi Arabia. 2015;56(2):109–14.

Google Scholar